Views for No evidence for selection of HIV-1 with enhanced gag-protease or nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.
Total visits
views | |
---|---|
No evidence for selection of HIV-1 with enhanced gag-protease or nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial. | 236 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Chopera_Denis_R_2013.pdf | 212 |
Chopera_Denis_R_2013.pdf(legacy) | 31 |
Top country views
views | |
---|---|
United States | 96 |
South Africa | 49 |
Germany | 18 |
Sweden | 17 |
Vietnam | 10 |
Finland | 4 |
Ireland | 4 |
India | 4 |
Netherlands | 4 |
China | 3 |
Russia | 3 |
France | 2 |
Moldova | 2 |
Brazil | 1 |
Canada | 1 |
Italy | 1 |
South Korea | 1 |
Romania | 1 |
Singapore | 1 |
Top city views
views | |
---|---|
Ashburn | 50 |
Johannesburg | 20 |
Hanoi | 10 |
Pretoria | 5 |
Bengaluru | 4 |
Dublin | 4 |
Washington | 3 |
Des Moines | 2 |
Durban | 2 |
New York | 2 |
Paris | 2 |
Santa Clara | 2 |
Andover | 1 |
Arezzo | 1 |
Asan | 1 |
Barueri | 1 |
Bucharest | 1 |
Chisinau | 1 |
Heidelberg | 1 |
Nanchang | 1 |
Sandton | 1 |
Seattle | 1 |
Singapore | 1 |
Stellenbosch | 1 |
Tzaneen | 1 |
Valencia | 1 |
Villieria | 1 |
West Palm Beach | 1 |